Suchergebnisse - "Uldrick, Thomas S"

PubPharm (143)

1

Exacerbation of CMV and Nontuberculous Mycobacterial Infections Following PD-1 Blockade for HIV-Associated Kaposi Sarcoma

enthalten in: Open forum infectious diseases | 2024

von Anidi, I. | Sakai, S. | Brooks, K. | +10

2

Remission after rituximab for HHV8+ MCD : what next?

enthalten in: Blood advances | 2023

von Ramaswami, R. | Uldrick, T.

CommentOn: Blood Adv. 2023 Sep 26;7(18):5663-5669. - PMID 37288720

3

Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesis

enthalten in: Journal of translational medicine | 2023

von Ramaswami, R. | Tagawa, T. | Mahesh, G. | +17

4

Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesis

enthalten in: Journal of translational medicine | 2023

von Ramaswami, R. | Tagawa, T. | Mahesh, G. | +17

5

Immunophenotypic analysis in participants with Kaposi sarcoma following pomalidomide administration

enthalten in: AIDS (London, England) | 2023

von Lurain, K. | Polizzotto, M. | Krug, L. | +8

6

Kaposi sarcoma herpesvirus viral load as a biomarker for leptomeningeal involvement by primary effusion lymphoma

enthalten in: Haematologica | 2023

von Lurain, K. | Ramaswami, R. | Marshall, V. | +14

7

A novel approach for characterization of KSHV‐associated multicentric Castleman disease from effusions

enthalten in: British Journal of Haematology | 2023

von Zhou, T. | Yuan, C. | Lurain, K. | +14

8

A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions

enthalten in: British journal of haematology | 2023

von Zhou, T. | Yuan, C. | Lurain, K. | +14

CommentIn: Br J Haematol. 2023 Feb;200(4):401-403. - PMID 36397674

9

Characteristics of patients admitted to the ICU with Kaposi sarcoma herpesvirus-associated diseases

enthalten in: AIDS (London, England) | 2022

von Hansen, M. | Mangusan, R. | Lurain, K. | +15

10

Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer

enthalten in: Journal for immunotherapy of cancer | 2022

von Odeny, T. | Lurain, K. | Strauss, J. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]